Global Recombinant Peptides Market Status and Outlook 2018-2025

July 2018 | 144 pages | ID: G5E607C525AEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Sandoz Pharma
• Stada Arzneimittel
• Amgen
• Hospira
• Actavis
• Cipla Ltd.
• Wockhardt Ltd.
• Biocon Ltd.

Market by Type

• Glucagon
• Calcitonin
• Others

Market by Application

• Oncology
• Blood Disorders
• Infectious Diseases
• Autoimmune Diseases
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Recombinant Peptides Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Glucagon
  3.1.2 Calcitonin
  3.1.3 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Oncology
  4.1.2 Blood Disorders
  4.1.3 Infectious Diseases
  4.1.4 Autoimmune Diseases
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Glucagon Production by Region
    6.1.1.2 Calcitonin Production by Region
    6.1.1.3 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Oncology Production by Region
    6.1.2.2 Blood Disorders Production by Region
    6.1.2.3 Infectious Diseases Production by Region
    6.1.2.4 Autoimmune Diseases Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Glucagon Demand by Region
    6.2.1.2 Calcitonin Demand by Region
    6.2.1.3 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Oncology Demand by Region
    6.2.2.2 Blood Disorders Demand by Region
    6.2.2.3 Infectious Diseases Demand by Region
    6.2.2.4 Autoimmune Diseases Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Sandoz Pharma
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Stada Arzneimittel
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Amgen
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Hospira
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Actavis
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Cipla Ltd.
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Wockhardt Ltd.
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Biocon Ltd.
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Recombinant Peptides Industry Dynamics & Regulations List
Table Global Recombinant Peptides Sales Revenue, Cost and Margin, 2015-2018E
Table Global Recombinant Peptides Market Status by Type 2015-2018E, in USD Million
Table Global Recombinant Peptides Market Status by Application 2015-2018E, in USD Million
Table Global Recombinant Peptides Market Status by Application 2015-2018E, in Volume
Table Global Recombinant Peptides Market by Region 2015-2018E, in USD Million
Table Global Recombinant Peptides Market Share by Region in 2018, in USD Million
Table Global Recombinant Peptides Market by Region 2015-2018E, in Volume
Table Global Recombinant Peptides Market Share by Region in 2018, in Volume
Table Glucagon Production Value by Region 2015-2018E, in USD Million
Table Glucagon Production Volume by Region 2015-2018E, in Volume
Table Calcitonin Production Value by Region 2015-2018E, in USD Million
Table Calcitonin Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Oncology Production Value by Region 2015-2018E, in USD Million
Table Oncology Production Volume by Region 2015-2018E, in Volume
Table Blood Disorders Production Value by Region 2015-2018E, in USD Million
Table Blood Disorders Production Volume by Region 2015-2018E, in Volume
Table Infectious Diseases Production Value by Region 2015-2018E, in USD Million
Table Infectious Diseases Production Volume by Region 2015-2018E, in Volume
Table Autoimmune Diseases Production Value by Region 2015-2018E, in USD Million
Table Autoimmune Diseases Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Glucagon Market Size by Region 2015-2018E, in USD Million
Table Glucagon Market Size by Region 2015-2018E, in Volume
Table Calcitonin Market Size by Region 2015-2018E, in USD Million
Table Calcitonin Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Oncology Market Size by Region 2015-2018E, in USD Million
Table Oncology Market Size by Region 2015-2018E, in Volume
Table Blood Disorders Market Size by Region 2015-2018E, in USD Million
Table Blood Disorders Market Size by Region 2015-2018E, in Volume
Table Infectious Diseases Market Size by Region 2015-2018E, in USD Million
Table Infectious Diseases Market Size by Region 2015-2018E, in Volume
Table Autoimmune Diseases Market Size by Region 2015-2018E, in USD Million
Table Autoimmune Diseases Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalRecombinant Peptides Forecast by Type 2019F-2025F, in USD Million
Table Recombinant Peptides Forecast by Type 2019F-2025F, in Volume
Table Recombinant Peptides Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Recombinant Peptides Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Recombinant Peptides Market Forecast by Region 2019F-2025F, in USD Million
Table Recombinant Peptides Market Forecast by Region 2019F-2025F, in Volume
Table Sandoz Pharma Information
Table Recombinant Peptides Sales, Cost, Margin of Sandoz Pharma
Table Stada Arzneimittel Information
Table Recombinant Peptides Sales, Cost, Margin of Stada Arzneimittel
Table Amgen Information
Table Recombinant Peptides Sales, Cost, Margin of Amgen
Table Hospira Information
Table Recombinant Peptides Sales, Cost, Margin of Hospira
Table Actavis Information
Table Recombinant Peptides Sales, Cost, Margin of Actavis
Table Cipla Ltd. Information
Table Recombinant Peptides Sales, Cost, Margin of Cipla Ltd.
Table Wockhardt Ltd. Information
Table Recombinant Peptides Sales, Cost, Margin of Wockhardt Ltd.
Table Biocon Ltd. Information
Table Recombinant Peptides Sales, Cost, Margin of Biocon Ltd.
Table Global Recombinant Peptides Sales Revenue by Company 2015-2017, in USD Million
Table Global Recombinant Peptides Sales Volume by Company 2015-2017, in Volume
Table Global Recombinant Peptides Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Recombinant Peptides Picture
Figure Recombinant Peptides Industry Chain Diagram
Figure Global Recombinant Peptides Sales Revenue 2015-2018E, in USD Million
Figure Global Recombinant Peptides Sales Volume 2015-2018E, in Volume
Figure Global Recombinant Peptides Market Status by Type 2015-2018E, in Volume
Figure North America Recombinant Peptides Market Size and Growth 2015-2018E, in USD Million
Figure North America Recombinant Peptides Market Size and Growth 2015-2018E, in Volume
Figure Europe Recombinant Peptides Market Size and Growth 2015-2018E, in USD Million
Figure Europe Recombinant Peptides Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Recombinant Peptides Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Recombinant Peptides Market Size and Growth 2015-2018E, in Volume
Figure South America Recombinant Peptides Market Size and Growth 2015-2018E, in USD Million
Figure South America Recombinant Peptides Market Size and Growth 2015-2018E, in Volume
Figure Middle East Recombinant Peptides Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Recombinant Peptides Market Size and Growth 2015-2018E, in Volume
Figure Africa Recombinant Peptides Market Size and Growth 2015-2018E, in USD Million
Figure Africa Recombinant Peptides Market Size and Growth 2015-2018E, in Volume
Figure Global Recombinant Peptides Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Recombinant Peptides Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Recombinant Peptides Sales Price Forecast 2019F-2025F
Figure Global Recombinant Peptides Gross Margin Forecast 2019F-2025F
Figure Global Recombinant Peptides Sales Revenue by Company in 2018, in USD Million
Figure Global Recombinant Peptides Price by Company in 2018
Figure Global Recombinant Peptides Gross Margin by Company in 2018